Tadayoshi Hirata

Mr. Hirata Joined AVM in April 2018.
Prior to Joining AVM, he worked in Innovation Management at Astellas Pharma Inc. (Japan) since April 2016, in charge of business transaction for early stage partnering deals.
From June 2009 to March 2016, he worked for Clinical Pharmacology Department at Astellas Pharma Inc. taking a lead in preparing early-stage clinical development plans utilizing translational science principles.
He also led clinical study protocol preparation and data analysis, and coordinated and managed preparation of applications for Clinical Pharmacology components, including Briefing Documents, INDs and NDAs and represented as a Clinical Pharmacology representative to the relevant regulatory authorities.
He started his job career as a research scientist at MSD (Former Banyu Pharmaceutical co., LTD.
a subsidiary of Merck & Co., Inc.) in April 2005 with background on pharmacokinetics and molecular biology.